BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324
1228 results:

  • 1. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection.
    Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
    Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions.
    Tavakkoli A; Beauchamp A; Prasad T; Zhu H; Singal AG; Elmunzer BJ; Kubiliun NM; Kwon RS; Hughes AE; Pruitt SL
    Cancer Med; 2024 Feb; 13(3):e7020. PubMed ID: 38400670
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk of Venous Thromboembolism by cancer Type: A Network Meta-Analysis.
    Betts MB; Liu X; Junqueira DR; Fahrbach K; Neupane B; Ronnebaum S; Dhamane AD
    Semin Thromb Hemost; 2024 Apr; 50(3):328-341. PubMed ID: 38395064
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population.
    Yuan C; Zou S; Wang K; Hu Z
    BMC Cancer; 2024 Feb; 24(1):227. PubMed ID: 38365630
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Effect of Renin-Angiotensin System Inhibitors in Patients Undergoing pancreatic cancer Resection.
    Abe S; Nakai Y; Arita J; Ichida A; Kawaguchi Y; Akamatsu N; Kaneko J; Ijichi H; Koike K; Fujishiro M; Hasegawa K
    Pancreas; 2024 Mar; 53(3):e233-e239. PubMed ID: 38227640
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long-term outcomes after surgical resection of pancreatic metastases from renal Clear-cell carcinoma.
    Boubaddi M; Marichez A; Adam JP; Chiche L; Laurent C
    Eur J Surg Oncol; 2024 Feb; 50(2):107960. PubMed ID: 38219701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Outcomes after distal pancreatectomy with or without splenectomy for intraductal papillary mucinous neoplasm: international multicentre cohort study.
    Gorris M; van Bodegraven EA; Abu Hilal M; Bolm L; Busch OR; Del Chiaro M; Habib J; Hasegawa K; He J; van Hooft JE; Jang JY; Javed AA; Kazami Y; Kwon W; Lee M; Liu R; Motoi F; Perri G; Saiura A; Salvia R; Sasanuma H; Takeda Y; Wolfgang C; Zelga P; Castillo CF; Marchegiani G; Besselink MG
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38195084
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
    Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Qualitative flow metabolic phenotype of pancreatic cancer. A new prognostic biomarker?
    Riviere D; Aarntzen E; van Geenen E; Chang D; de Geus-Oei LF; Brosens L; van Laarhoven K; Gotthardt M; Hermans J
    HPB (Oxford); 2024 Mar; 26(3):389-399. PubMed ID: 38114400
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Serum elastase-1 predicts malignancy in intraductal papillary mucinous neoplasm of the pancreas.
    Mishima T; Takano S; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Konishi T; Nishino H; Nakada S; Kouchi Y; Kishimoto T; Ohtsuka M
    Pancreatology; 2024 Feb; 24(1):93-99. PubMed ID: 38102054
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Technical Strategy for pancreatic Body cancers: A Raison d'etre of Distal Pancreatectomy with Portal Resection.
    Maekawa A; Oba A; Inoue Y; Omiya K; Ono Y; Sato T; Watanabe S; Uchino Y; Kobayashi K; Ito H; Sato Y; Tanabe M; Saiura A; Takahashi Y
    Ann Surg Oncol; 2024 Feb; 31(2):1347-1357. PubMed ID: 37952022
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous Oligometastases.
    Inoue K; Mizuma M; Motoi F; Kokumai T; Sato H; Kusaka A; Aoki S; Iseki M; Douchi D; Miura T; Maeda S; Ishida M; Ohtsuka H; Nakagawa K; Kamei T; Unno M
    Anticancer Res; 2023 Nov; 43(11):5223-5234. PubMed ID: 37909951
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced pancreatic cancer: A Multicenter Retrospective Study.
    Lee J; Park JS; Jeong S; Lee DH; Lim JH; Cho SG; Kwon CI; Hyun JJ; Choe JW; Cho JH; Jang SI
    Turk J Gastroenterol; 2023 Dec; 34(12):1249-1256. PubMed ID: 37860834
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. cancers attributable to overweight and obesity in Italy.
    Di Maso M; Pelucchi C; Collatuzzo G; Alicandro G; Malvezzi M; Parazzini F; Negri E; Boffetta P; La Vecchia C; Turati F
    Cancer Epidemiol; 2023 Dec; 87():102468. PubMed ID: 37832242
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life pancreatic cancer Patients: Focus on Pain Management and Psychiatric Therapies.
    Allen JM; Awunti M; Guo Y; Bian J; Rogers SC; Scarton L; DeRemer DL; Wilkie DJ
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1675-1682. PubMed ID: 37788369
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Site-specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany.
    Grundmann N; Voigtländer S; Hakimhashemi A; Pape UF; Meyer M; Müller-Nordhorn J
    Cancer Med; 2023 Oct; 12(19):19949-19958. PubMed ID: 37737059
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system.
    Xu Y; Liu W; Long Z; Wang L; Zhou M; Yin P
    BMC Cancer; 2023 Sep; 23(1):893. PubMed ID: 37735368
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between sodium-glucose cotransporter 2 inhibitors and pancreatic cancer in the Japanese working-age population.
    Tanaka Y; Yokoyama S; Nakagawa C; Uno T; Hosomi K
    Int J Clin Pharmacol Ther; 2023 Nov; 61(11):492-502. PubMed ID: 37644877
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluation of postoperative outcomes of minimally invasive distal pancreatectomy for left-sided pancreatic tumors based on the modified frailty index: a retrospective cohort study.
    Park Y; Hwang DW; Lee JH; Song KB; Jun E; Lee W; Kwak BJ; Kim SC
    Int J Surg; 2023 Nov; 109(11):3497-3505. PubMed ID: 37598358
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical features and prognostic factors of spinal metastatic pancreatic cancer: A retrospective observational study.
    Yun JH; Cho PG; Kim KT; Shin DA; Kim KN; Kim SH; Noh SH
    Medicine (Baltimore); 2023 Jul; 102(28):e34264. PubMed ID: 37443474
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 62.